nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxprenolol—SLC22A2—Cisplatin—esophageal cancer	0.749	1	CbGbCtD
Oxprenolol—Methocarbamol—CA1—esophageal cancer	0.0373	0.771	CrCbGaD
Oxprenolol—Atenolol—ABCB1—esophageal cancer	0.00358	0.074	CrCbGaD
Oxprenolol—Acebutolol—ABCB1—esophageal cancer	0.00331	0.0683	CrCbGaD
Oxprenolol—Metoprolol—ABCB1—esophageal cancer	0.00279	0.0577	CrCbGaD
Oxprenolol—Propranolol—ABCB1—esophageal cancer	0.00141	0.0291	CrCbGaD
Oxprenolol—ADRB1—Calcium Regulation in the Cardiac Cell—SFN—esophageal cancer	0.00135	0.00667	CbGpPWpGaD
Oxprenolol—ADRB2—Calcium Regulation in the Cardiac Cell—GNG7—esophageal cancer	0.00133	0.00658	CbGpPWpGaD
Oxprenolol—ADRB2—Calcium Regulation in the Cardiac Cell—SFN—esophageal cancer	0.00132	0.00653	CbGpPWpGaD
Oxprenolol—SLC22A2—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.00132	0.00652	CbGpPWpGaD
Oxprenolol—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.00122	0.00601	CbGpPWpGaD
Oxprenolol—SLC22A2—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.00121	0.00596	CbGpPWpGaD
Oxprenolol—CYP2D6—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.0012	0.00593	CbGpPWpGaD
Oxprenolol—ADRB1—Calcium Regulation in the Cardiac Cell—CALR—esophageal cancer	0.00108	0.00531	CbGpPWpGaD
Oxprenolol—ADRB2—Calcium Regulation in the Cardiac Cell—CALR—esophageal cancer	0.00105	0.00519	CbGpPWpGaD
Oxprenolol—CYP2D6—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.00105	0.00518	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmission across Chemical Synapses—GNG7—esophageal cancer	0.00102	0.00506	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—ADCYAP1—esophageal cancer	0.00102	0.00504	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—ADCYAP1—esophageal cancer	0.000999	0.00493	CbGpPWpGaD
Oxprenolol—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000986	0.00487	CbGpPWpGaD
Oxprenolol—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.00098	0.00484	CbGpPWpGaD
Oxprenolol—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000968	0.00478	CbGpPWpGaD
Oxprenolol—ADRB2—Arf6 signaling events—EGFR—esophageal cancer	0.000963	0.00475	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.000959	0.00474	CbGpPWpGaD
Oxprenolol—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000935	0.00462	CbGpPWpGaD
Oxprenolol—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000922	0.00455	CbGpPWpGaD
Oxprenolol—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.00091	0.00449	CbGpPWpGaD
Oxprenolol—CYP2D6—Biological oxidations—ADH7—esophageal cancer	0.000902	0.00445	CbGpPWpGaD
Oxprenolol—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000795	0.00393	CbGpPWpGaD
Oxprenolol—CYP2D6—Biological oxidations—ADH1B—esophageal cancer	0.000791	0.00391	CbGpPWpGaD
Oxprenolol—SLC22A2—Neuronal System—GNG7—esophageal cancer	0.000784	0.00387	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000752	0.00372	CbGpPWpGaD
Oxprenolol—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000747	0.00369	CbGpPWpGaD
Oxprenolol—CYP2D6—Biological oxidations—CYP26A1—esophageal cancer	0.000735	0.00363	CbGpPWpGaD
Oxprenolol—SLC22A2—Neuronal System—ALDH2—esophageal cancer	0.000735	0.00363	CbGpPWpGaD
Oxprenolol—CYP2D6—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000725	0.00358	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000707	0.00349	CbGpPWpGaD
Oxprenolol—CYP2D6—Biological oxidations—GSTO1—esophageal cancer	0.000683	0.00338	CbGpPWpGaD
Oxprenolol—CYP2D6—Metapathway biotransformation—GSTO1—esophageal cancer	0.000674	0.00333	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.00067	0.00331	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL2—esophageal cancer	0.000662	0.00327	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL2—esophageal cancer	0.000648	0.0032	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.00064	0.00316	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ANXA1—esophageal cancer	0.000616	0.00304	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000613	0.00303	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000613	0.00303	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ANXA1—esophageal cancer	0.000602	0.00297	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—SST—esophageal cancer	0.000599	0.00296	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—SST—esophageal cancer	0.000586	0.00289	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GHRL—esophageal cancer	0.000584	0.00288	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—ADCYAP1—esophageal cancer	0.000577	0.00285	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—GNG7—esophageal cancer	0.000572	0.00283	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GHRL—esophageal cancer	0.000571	0.00282	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—ADCYAP1—esophageal cancer	0.000564	0.00279	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—GNG7—esophageal cancer	0.00056	0.00277	CbGpPWpGaD
Oxprenolol—CYP2D6—Biological oxidations—ALDH2—esophageal cancer	0.000557	0.00275	CbGpPWpGaD
Oxprenolol—CYP2D6—Biological oxidations—GSTT1—esophageal cancer	0.00053	0.00262	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—ADCYAP1—esophageal cancer	0.000524	0.00259	CbGpPWpGaD
Oxprenolol—CYP2D6—Biological oxidations—CYP2A6—esophageal cancer	0.000524	0.00259	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—ADCYAP1—esophageal cancer	0.000513	0.00253	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—CXCL2—esophageal cancer	0.000504	0.00249	CbGpPWpGaD
Oxprenolol—CYP2D6—Biological oxidations—PTGS1—esophageal cancer	0.000497	0.00245	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—CXCL2—esophageal cancer	0.000493	0.00244	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GDI2—esophageal cancer	0.00048	0.00237	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GDI2—esophageal cancer	0.00047	0.00232	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—ANXA1—esophageal cancer	0.000469	0.00232	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000465	0.0023	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—ANXA1—esophageal cancer	0.000459	0.00227	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—SST—esophageal cancer	0.000456	0.00225	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—SST—esophageal cancer	0.000446	0.0022	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—GHRL—esophageal cancer	0.000444	0.0022	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—GHRL—esophageal cancer	0.000435	0.00215	CbGpPWpGaD
Oxprenolol—CYP2D6—Biological oxidations—CYP1B1—esophageal cancer	0.000422	0.00209	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000422	0.00208	CbGpPWpGaD
Oxprenolol—CYP2D6—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000416	0.00206	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—BLVRB—esophageal cancer	0.000414	0.00205	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—SLC52A3—esophageal cancer	0.000414	0.00205	CbGpPWpGaD
Oxprenolol—CYP2D6—Biological oxidations—CYP19A1—esophageal cancer	0.000397	0.00196	CbGpPWpGaD
Oxprenolol—CYP2D6—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000391	0.00193	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—AKAP13—esophageal cancer	0.000372	0.00184	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—AKAP13—esophageal cancer	0.000364	0.0018	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—SLC10A2—esophageal cancer	0.000352	0.00174	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CA1—esophageal cancer	0.000352	0.00174	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—KMT2D—esophageal cancer	0.000347	0.00172	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PDE4D—esophageal cancer	0.00034	0.00168	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—KMT2D—esophageal cancer	0.00034	0.00168	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—AKAP13—esophageal cancer	0.000338	0.00167	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PDE4D—esophageal cancer	0.000333	0.00164	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—AKAP13—esophageal cancer	0.00033	0.00163	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—GNG7—esophageal cancer	0.000323	0.0016	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CA2—esophageal cancer	0.000322	0.00159	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—GNG7—esophageal cancer	0.000316	0.00156	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ADCYAP1—esophageal cancer	0.00031	0.00153	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PDE4D—esophageal cancer	0.000309	0.00153	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ADCYAP1—esophageal cancer	0.000303	0.0015	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PDE4D—esophageal cancer	0.000302	0.00149	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PLCE1—esophageal cancer	0.0003	0.00148	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ADH7—esophageal cancer	0.0003	0.00148	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—GNG7—esophageal cancer	0.000294	0.00145	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—GNG7—esophageal cancer	0.000287	0.00142	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—CXCL2—esophageal cancer	0.000285	0.00141	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—WWOX—esophageal cancer	0.000283	0.0014	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—CXCL2—esophageal cancer	0.000279	0.00138	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—WWOX—esophageal cancer	0.000277	0.00137	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—FKBP1A—esophageal cancer	0.000269	0.00133	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—ANXA1—esophageal cancer	0.000265	0.00131	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FKBP1A—esophageal cancer	0.000263	0.0013	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—WIF1—esophageal cancer	0.000263	0.0013	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ADH1B—esophageal cancer	0.000263	0.0013	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—ANXA1—esophageal cancer	0.000259	0.00128	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—CXCL2—esophageal cancer	0.000259	0.00128	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—SST—esophageal cancer	0.000258	0.00127	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—WIF1—esophageal cancer	0.000257	0.00127	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000257	0.00127	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—CXCL2—esophageal cancer	0.000253	0.00125	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—SST—esophageal cancer	0.000252	0.00125	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—GHRL—esophageal cancer	0.000251	0.00124	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—TYMP—esophageal cancer	0.000251	0.00124	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000247	0.00122	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—GHRL—esophageal cancer	0.000246	0.00121	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CYP26A1—esophageal cancer	0.000244	0.00121	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CSNK1A1—esophageal cancer	0.000243	0.0012	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—ANXA1—esophageal cancer	0.000241	0.00119	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ALOX15—esophageal cancer	0.000238	0.00118	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CSNK1A1—esophageal cancer	0.000238	0.00117	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—ANXA1—esophageal cancer	0.000235	0.00116	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—SST—esophageal cancer	0.000234	0.00116	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—SST—esophageal cancer	0.000229	0.00113	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—GHRL—esophageal cancer	0.000228	0.00113	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PFN1—esophageal cancer	0.000227	0.00112	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GSTO1—esophageal cancer	0.000227	0.00112	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—TPI1—esophageal cancer	0.000227	0.00112	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—GHRL—esophageal cancer	0.000223	0.0011	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PFN1—esophageal cancer	0.000222	0.0011	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ALDOB—esophageal cancer	0.000218	0.00108	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—BLVRB—esophageal cancer	0.000213	0.00105	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SLC52A3—esophageal cancer	0.000213	0.00105	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GAPDH—esophageal cancer	0.00021	0.00103	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CRABP1—esophageal cancer	0.000208	0.00103	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ELMO1—esophageal cancer	0.000204	0.00101	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ELMO1—esophageal cancer	0.0002	0.000986	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—AKAP13—esophageal cancer	0.000199	0.000985	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GNG7—esophageal cancer	0.000197	0.000975	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—AKAP13—esophageal cancer	0.000195	0.000964	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ALDH2—esophageal cancer	0.000185	0.000914	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000184	0.000909	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PDE4D—esophageal cancer	0.000182	0.000901	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CA1—esophageal cancer	0.000181	0.000896	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SLC10A2—esophageal cancer	0.000181	0.000896	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HIST1H2BM—esophageal cancer	0.00018	0.000889	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PDE4D—esophageal cancer	0.000178	0.000882	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GSTT1—esophageal cancer	0.000176	0.000869	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CYP2A6—esophageal cancer	0.000174	0.000859	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GNG7—esophageal cancer	0.000174	0.000857	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GNG7—esophageal cancer	0.00017	0.000838	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CA2—esophageal cancer	0.000166	0.000819	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PTGS1—esophageal cancer	0.000165	0.000815	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ENO1—esophageal cancer	0.000165	0.000815	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000165	0.000814	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—XIAP—esophageal cancer	0.000163	0.000803	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PSME2—esophageal cancer	0.000163	0.000803	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PSME1—esophageal cancer	0.000163	0.000803	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—XIAP—esophageal cancer	0.000159	0.000786	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PLCE1—esophageal cancer	0.000154	0.000762	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ADH7—esophageal cancer	0.000154	0.000762	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CTNNA1—esophageal cancer	0.000154	0.00076	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CXCL2—esophageal cancer	0.000153	0.000755	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CTNNA1—esophageal cancer	0.00015	0.000743	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CXCL2—esophageal cancer	0.00015	0.000739	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PSME1—esophageal cancer	0.000143	0.000705	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PSME2—esophageal cancer	0.000143	0.000705	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ANXA1—esophageal cancer	0.000142	0.000702	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CYP1B1—esophageal cancer	0.00014	0.000693	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PSME2—esophageal cancer	0.00014	0.00069	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PSME1—esophageal cancer	0.00014	0.00069	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ANXA1—esophageal cancer	0.000139	0.000687	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SST—esophageal cancer	0.000138	0.000683	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SST—esophageal cancer	0.000135	0.000668	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ADH1B—esophageal cancer	0.000135	0.000668	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NOTCH3—esophageal cancer	0.000135	0.000666	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GHRL—esophageal cancer	0.000135	0.000666	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—FBXW7—esophageal cancer	0.000133	0.000655	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CYP19A1—esophageal cancer	0.000132	0.000651	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NOTCH3—esophageal cancer	0.000132	0.000651	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GHRL—esophageal cancer	0.000132	0.000651	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FBXW7—esophageal cancer	0.00013	0.000641	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—TYMP—esophageal cancer	0.000129	0.000638	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP26A1—esophageal cancer	0.000126	0.000621	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ALOX15—esophageal cancer	0.000123	0.000605	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NOTCH2—esophageal cancer	0.000121	0.000597	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—HMOX1—esophageal cancer	0.00012	0.000594	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NOTCH2—esophageal cancer	0.000118	0.000584	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—TPI1—esophageal cancer	0.000117	0.000577	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GSTO1—esophageal cancer	0.000117	0.000577	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ABCB1—esophageal cancer	0.000115	0.00057	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ALDOB—esophageal cancer	0.000112	0.000553	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GAPDH—esophageal cancer	0.000108	0.000533	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TGFBR2—esophageal cancer	0.000107	0.00053	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CRABP1—esophageal cancer	0.000107	0.000528	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TGFBR2—esophageal cancer	0.000105	0.000518	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GNG7—esophageal cancer	0.000102	0.000502	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SMAD4—esophageal cancer	0.000101	0.000501	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SMAD4—esophageal cancer	9.93e-05	0.00049	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ALDH2—esophageal cancer	9.53e-05	0.000471	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GSTT1—esophageal cancer	9.06e-05	0.000448	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP2A6—esophageal cancer	8.96e-05	0.000442	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ENO1—esophageal cancer	8.49e-05	0.000419	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PTGS1—esophageal cancer	8.49e-05	0.000419	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PSME2—esophageal cancer	8.37e-05	0.000413	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PSME1—esophageal cancer	8.37e-05	0.000413	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HIF1A—esophageal cancer	8.3e-05	0.00041	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HIF1A—esophageal cancer	8.12e-05	0.000401	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—KDR—esophageal cancer	7.94e-05	0.000392	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—KDR—esophageal cancer	7.77e-05	0.000384	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CREBBP—esophageal cancer	7.72e-05	0.000381	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NOTCH1—esophageal cancer	7.48e-05	0.00037	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NOTCH1—esophageal cancer	7.32e-05	0.000361	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP1B1—esophageal cancer	7.22e-05	0.000357	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—NOS3—esophageal cancer	6.91e-05	0.000341	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP19A1—esophageal cancer	6.79e-05	0.000335	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CREBBP—esophageal cancer	6.78e-05	0.000335	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—EGFR—esophageal cancer	6.67e-05	0.000329	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CREBBP—esophageal cancer	6.63e-05	0.000328	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—EGFR—esophageal cancer	6.52e-05	0.000322	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PIK3CA—esophageal cancer	6.37e-05	0.000315	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PTGS2—esophageal cancer	6.32e-05	0.000312	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PIK3CA—esophageal cancer	6.23e-05	0.000308	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—HMOX1—esophageal cancer	6.19e-05	0.000306	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NOS3—esophageal cancer	6.07e-05	0.0003	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ABCB1—esophageal cancer	5.95e-05	0.000294	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NOS3—esophageal cancer	5.94e-05	0.000293	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PIK3CA—esophageal cancer	5.78e-05	0.000286	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ERBB2—esophageal cancer	5.68e-05	0.000281	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PIK3CA—esophageal cancer	5.66e-05	0.000279	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ERBB2—esophageal cancer	5.56e-05	0.000274	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—EP300—esophageal cancer	5.26e-05	0.00026	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CCND1—esophageal cancer	5.02e-05	0.000248	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CCND1—esophageal cancer	4.91e-05	0.000242	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CDKN1A—esophageal cancer	4.85e-05	0.00024	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CDKN1A—esophageal cancer	4.75e-05	0.000235	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—EP300—esophageal cancer	4.62e-05	0.000228	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—EP300—esophageal cancer	4.52e-05	0.000223	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MYC—esophageal cancer	4.03e-05	0.000199	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CREBBP—esophageal cancer	3.97e-05	0.000196	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MYC—esophageal cancer	3.94e-05	0.000194	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—EGFR—esophageal cancer	3.94e-05	0.000194	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PIK3CA—esophageal cancer	3.89e-05	0.000192	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—EGFR—esophageal cancer	3.85e-05	0.00019	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NOS3—esophageal cancer	3.56e-05	0.000176	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PIK3CA—esophageal cancer	3.42e-05	0.000169	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PIK3CA—esophageal cancer	3.34e-05	0.000165	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TP53—esophageal cancer	3.31e-05	0.000163	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PTGS2—esophageal cancer	3.25e-05	0.000161	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TP53—esophageal cancer	3.23e-05	0.00016	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—EP300—esophageal cancer	2.71e-05	0.000134	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PIK3CA—esophageal cancer	2e-05	9.89e-05	CbGpPWpGaD
